Sano Bioscience Int'l  
 
 

About Sano

SBI's mission is to be a conduit between thought leaders in clinical development and pioneer biotech companies that have set out to cure the world. Sano is Latin meaning 'to heal'. We take our role in changing people's lives seriously.

The partners of SBI have been successfully serving clients for more than two decades. Our partners have an average of over a decade of recruiting experience and prior to forming SBI, served as partners and principals in leading recruiting and executive search firms.

Clients

Acadia Pharmaceuticals, Inc.
Agouron Pharmaceuticals, Inc. (now Pfizer)
Alta Partners
Axys Pharmaceuticals, Inc. (now Celera Genomics)
Arizeke Pharmaceuticals, Inc.
Ciblex Corporation
CombiChem (now DuPont Pharmaceuticals)
Corvas International, Inc
Elitra Pharmaceuticals, Inc
Forward Ventures
Genetronics Biomedical Inc.
Genicon Sciences (now Invitrogen Corporation)
Genos (Joint venture of Sequana and Sloan-Kettering Institute)
Houghton Pharmaceuticals (now Lion Biosciences)
Immunogenex
Kemia
Ligand Pharmaceuticals
LJL BioSystems, Inc.
LXR Biotechnology, Inc.
MitoKor
Molecular Biosystems, Inc.
Molecular Devices Corporation
Nereus Pharmaceuticals
Neurocrine Biosciences, Inc.
Plexxikon, Inc.
Prizm (now Selective Genetics)
Quidel Corporation
Senomyx
Sepracore (Currently Versicor)
SeQual Technologies
Sequana (now Axys Pharmaceuticals, Inc.- Southern California)
Sibia Neurosciences, Inc. (now Merck Research Laboratories)
Signal Pharmaceuticals
Structural GenomiX
Sunesis Pharmaceuticals Inc
Syngenta
TPG Ventures

Recent Placed Bios

Recent Placement Bio's

Chief Medical Officer

Sano Bioscience placed a candidate who was a rarity in his field. Beginning as a student at UC Berkeley where they received their Departmental Citation as the top graduate. He then continued their study at UC San Francisco being invited into the Alpha Omega Alpha Medical Honor Society and became a Hematology-Oncology Fellow. After receiving his MD from Harvard he went on to bring this same caliber of work into industry. Recently at a biotech start-up, he built and led the clinical development team that successfully moved multiple candidates through the pipeline. In this role, he was able to achieve the results to build a company that now has a market valuation over $1B.


 
© 2004 copyright Sano Biosciences International, Inc.